Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis

BMJ Open

Volumn 3, Issue 6, 2013, Pages

  Dwan, Kerry ^a   Kirkham, Jamie J ^a   Williamson, Paula R ^a   Gamble, Carrol ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; HUMAN; OUTCOME ASSESSMENT; OUTCOME REPORTING BIAS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC ERROR; SYSTEMATIC REVIEW (TOPIC);

EID: 84878755024     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002709     Document Type: Article

References (20)

1. Green SB, Byar DP. Using observational data from registries to compare treatments: the fallacy of omnimetrics. Stat Med 1984; 3: 361-73.
2. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS ONE 2010; 5: e9810.
3. Jüni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6. (Pubitemid 32682008)
4. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat 2000; 49: 359-70.
5. Williamson PR, Gamble C, Altman DG, et al. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005;14:515-24. (Pubitemid 41489523)
6. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008; 3: e3081.
7. Kirkham JJ, Dwan K, Dodd S, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010; 340: c365.
8. Von Mosch S, Dwan K. Reporting of harm and efficacy outcomes of randomised clinical trials in cystic fibrosis before and after the publication of the revised CONSORT (CONsolidated Standards Of Reporting Trials) statement in 2001- a comparison of trial reports published from 1994 and from 2008 [thesis]. The University of Liverpool, 2011.
9. The Cochrane Library, Issue 4, Chichester: Wiley, 2009.
10. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org
11. Williamson PR, Gamble C. Identification and impact of outcome selection bias in meta-analysis. Stat Med 2005;24:1547-61. (Pubitemid 40716353)
12. Copas J, Jackson D. A bound for publication bias based on the fraction 14 of unpublished studies. Biometrics 2004; 60: 146-53.
13. Williamson PR, Gamble C. Application and investigation of a bound for outcome reporting bias. Trials 2007; 8: 9.
14. Dwan K, Gamble C, Kolamunnage-Dona R, et al. Assessing the potential for outcome reporting bias in a review: a tutorial. Trials 2010; 11: 52.
15. Copas J, Dwan K, Kirkham JJ, et al. A model based correction for outcome reporting bias in meta-analysis. Biostatistics 2013. In press.
16. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr 1994;124:177-92. (Pubitemid 24057781)
17. Sinha I, Jones L, Smyth RL, et al. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Med 2008; 5: e96.
18. Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials 2007; 8: 39.
19. Kirkham JJ, Riley RD, Williamson PR. A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews. Stat Med 2012; 31: 2179-95.
20. Smyth AR, Walters S. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2003;( 3): CD001912.